Skip to content

Magnetic seizure Therapy(MST) for Depression: a Resting-state Functional Magnetic Resonance Imaging Study

Magnetic seizure Therapy(MST) for Depression: a Resting-state Functional Magnetic Resonance Imaging Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RNC-17014100
Enrollment
Unknown
Registered
2017-12-22
Start date
2017-10-09
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

case group:MST

Sponsors

Beijing Anding Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. aged 18-60 years old male and female; 2. met the diagnostic criteria for a major depressive disorder as diagnosed with the Diagnostic Manual for Mental Disorders (DSM-IV); 3. Hamilton Rating Scale for Depression(HAMD)=17(17 item); 4. Convulsive therapy clinically indicated; 5. right hand; 6. Willing and capable of providing informed consent.

Exclusion criteria

Exclusion criteria: 1. Not suitable for ECT treatment, such as organic mental disorder, severe physical illness, substance abuse, head trauma, history of epilepsy, Parkinson's disease and other neurological disorders; 2. History of schizophrenia, schizoaffective disorder, bipolar disorder; 3. planning on getting pregnant or pregnancy; 4. allergic to anesthetics and muscle relaxants; 5. Patients wear devices that may be affected by repetitive transcranial magnetic stimulation (cardiac pacemakers, drug pumps, cochlear implants, brain stimulators, eye implants, etc.) or unsuitable for magnetic resonance scanning (If claustrophobic, etc.); 6. History of ECT in the past 6 months or Failure to respond to an adequate course of ECT in the past.

Design outcomes

Primary

MeasureTime frame
17-HAMD;

Countries

China

Contacts

Public ContactXin Ma

Beijing Anding Hospital, Capital Medical University

maxinanding@vip.163.com+86 13701364608

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026